Terms: = Bone cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
201 results:
1. Multiple pathological fractures and muscle atrophy caused by a parathyroid carcinoma with postoperative hungry bone syndrome: A case report.
Liu Q; Zhang Y; Ma D; Gengzhi H; Maimaiti Y; Chen Q; Ma Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2047. PubMed ID: 38577726
[TBL] [Abstract] [Full Text] [Related]
2. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Murthy HS; Zhang MJ; Chen K; Ahmed S; Deotare U; Ganguly S; Kansagra A; Michelis FV; Nishihori T; Patnaik M; Abid MB; Aljurf M; Arai Y; Bacher U; Badar T; Badawy SM; Ballen K; Battiwalla M; Beitinjaneh A; Bejanyan N; Bhatt VR; Brown VI; Martino R; Cahn JY; Castillo P; Cerny J; Chhabra S; Copelan E; Daly A; Dholaria B; Diaz Perez MA; Freytes CO; Grunwald MR; Hashmi S; Hildebrandt GC; Jamy O; Joseph J; Kanakry CG; Khera N; Krem MM; Kuwatsuka Y; Lazarus HM; Lekakis LJ; Liu H; Modi D; Munshi PN; Mussetti A; Palmisiano N; Patel SS; Rizzieri DA; Seo S; Shah MV; Sharma A; Sohl M; Solomon SR; Ulrickson M; Ustun C; van der Poel M; Verdonck LF; Wagner JL; Wang T; Wirk B; Zeidan A; Litzow M; Kebriaei P; Hourigan CS; Weisdorf DJ; Saber W; Kharfan-Dabaja MA
Blood Adv; 2023 Nov; 7(22):7007-7016. PubMed ID: 37792849
[TBL] [Abstract] [Full Text] [Related]
4. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ;
Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China.
Zhang Y; Ding L; Zheng Y; Wang K; Xia W; Wang J; Ge P
PeerJ; 2023; 11():e14500. PubMed ID: 36624752
[TBL] [Abstract] [Full Text] [Related]
6.
Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
[TBL] [Abstract] [Full Text] [Related]
7. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Kaptein FHJ; Stals MAM; Evenhuis RE; Gelderblom H; Huisman MV; Karis DSA; Noten RWD; Cannegieter SC; Speetjens FM; Verschoor AJ; Versteeg HH; van de Sande MAJ; Klok FA
Thromb Res; 2023 Jan; 221():19-25. PubMed ID: 36435048
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of COVID-19 patients in danger of death using radiomic features of portable chest radiographs.
Nakashima M; Uchiyama Y; Minami H; Kasai S
J Med Radiat Sci; 2023 Mar; 70(1):13-20. PubMed ID: 36334033
[TBL] [Abstract] [Full Text] [Related]
9. Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Van Oekelen O; Nath K; Mouhieddine TH; Farzana T; Aleman A; Melnekoff DT; Ghodke-Puranik Y; Shah GL; Lesokhin A; Giralt S; Thibaud S; Rossi A; Rodriguez C; Sanchez L; Richter J; Richard S; Cho HJ; Chari A; Usmani SZ; Jagannath S; Shah UA; Mailankody S; Parekh S
Blood; 2023 Feb; 141(7):756-765. PubMed ID: 36327160
[TBL] [Abstract] [Full Text] [Related]
10. Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia.
Kubota Y; Zawit M; Durrani J; Shen W; Bahaj W; Kewan T; Ponvilawan B; Mori M; Meggendorfer M; Gurnari C; LaFramboise T; Feurstein S; Sekeres MA; Visconte V; Godley LA; Haferlach T; Maciejewski JP
Leukemia; 2022 Dec; 36(12):2827-2834. PubMed ID: 36266327
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility and preliminary efficacy of tantalum components in the management of acetabular reconstruction following periacetabular oncologic resection in primary malignancies.
Zan P; Ma X; Wang H; Cai Z; Shen J; Sun W
Eur J Med Res; 2022 Aug; 27(1):151. PubMed ID: 35978388
[TBL] [Abstract] [Full Text] [Related]
12. Spinal cord compression of neoplastic origin: surgical experience using a common clinical language.
Godino O; Visus I; Garreta I; Lopez-Obarrio L; González-Cañas L; Sanchez JJ; Marin M; Montero A; Pérez H; Asiaín L; Navarro-Martin A
Clin Transl Oncol; 2022 Oct; 24(10):1932-1939. PubMed ID: 35653005
[TBL] [Abstract] [Full Text] [Related]
13. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Terbuch A; Posch F; Bauernhofer T; Jost PJ; Partl R; Stranzl-Lawatsch H; Baciarello G; Fizazi K; Giannatempo P; Verzoni E; Sweeney C; Ravi P; Tran B; Basso U; White J; Vincenzi B; Oing C; Cutuli HJ; Dieckmann KP; Gamulin M; Chovanec M; Fankhauser CD; Heidenreich A; Mohamad O; Thibault C; Fischer S; Gillessen S;
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):825-832. PubMed ID: 35461737
[TBL] [Abstract] [Full Text] [Related]
15. Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Kinoshita H; Cooke KR; Grant M; Stanojevic M; Cruz CR; Keller M; Fortiz MF; Hoq F; Lang H; Barrett AJ; Liang H; Tanna J; Zhang N; Shibli A; Datar A; Fulton K; Kukadiya D; Zhang A; Williams KM; Dave H; Dome JS; Jacobsohn D; Hanley PJ; Jones RJ; Bollard CM
Blood Adv; 2022 Apr; 6(8):2520-2534. PubMed ID: 35244681
[TBL] [Abstract] [Full Text] [Related]
16. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract] [Full Text] [Related]
17. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
Pasca S; Chifotides HT; Verstovsek S; Bose P
Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
[TBL] [Abstract] [Full Text] [Related]
18. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
[No Abstract] [Full Text] [Related]
19. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Bishop MR; Dickinson M; Purtill D; Barba P; Santoro A; Hamad N; Kato K; Sureda A; Greil R; Thieblemont C; Morschhauser F; Janz M; Flinn I; Rabitsch W; Kwong YL; Kersten MJ; Minnema MC; Holte H; Chan EHL; Martinez-Lopez J; Müller AMS; Maziarz RT; McGuirk JP; Bachy E; Le Gouill S; Dreyling M; Harigae H; Bond D; Andreadis C; McSweeney P; Kharfan-Dabaja M; Newsome S; Degtyarev E; Awasthi R; Del Corral C; Andreola G; Masood A; Schuster SJ; Jäger U; Borchmann P; Westin JR
N Engl J Med; 2022 Feb; 386(7):629-639. PubMed ID: 34904798
[TBL] [Abstract] [Full Text] [Related]
20. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Locke FL; Miklos DB; Jacobson CA; Perales MA; Kersten MJ; Oluwole OO; Ghobadi A; Rapoport AP; McGuirk J; Pagel JM; Muñoz J; Farooq U; van Meerten T; Reagan PM; Sureda A; Flinn IW; Vandenberghe P; Song KW; Dickinson M; Minnema MC; Riedell PA; Leslie LA; Chaganti S; Yang Y; Filosto S; Shah J; Schupp M; To C; Cheng P; Gordon LI; Westin JR;
N Engl J Med; 2022 Feb; 386(7):640-654. PubMed ID: 34891224
[TBL] [Abstract] [Full Text] [Related]
[Next]
